Canopy Growth to supply four Canadian flower strains to UK medical market
GROW Group will distribute the Kincardine-grown flower in Britain under Canopy's Spectrum Therapeutics medical brand.
Adrian Kessler· Sep 22
Trulieve added to S&P Total Market and Completion indices after Delaware redomicile
Vanguard's Extended Market Index Fund, which held US$95.4 billion on Aug. 31, tracks one of the two benchmarks that took the shares in.
Analysis
Radisson Mining drills 68.24 g/t gold over 6.2 metres beneath the old O'Brien mine
One metre of the intercept assayed 384.01 grams per tonne, and Agnico Eagle now holds 10.45 per cent of the Quebec explorer.
NASDAQ: MSTR
Strategy resumes bitcoin buying with 950 BTC after a two week pause
The company spent US$174 million buying back its Stretch preferred stock over the same week, more than twice what it put into bitcoin.
NASDAQ: NUAI
New Era Energy jumps 31% on 20-year Vistra power deal for its Texas data centreThe contract obliges New Era to post a letter of credit of US$116 million within 15 business days of the Sept. 18 signing.
TSE: GENM
Generation Mining closes C$240M share sale for its Marathon copper-palladium mineCanada Growth Fund came out of the sale holding 19.9 per cent of the developer, whose Marathon copper-palladium mine starts early works in the fourth quarter.
Analysis
Georgia Power and Google to fund 96 MW of nuclear uprates at Vogtle and Hatch
Under filings made Monday with Georgia regulators, Google's subscription would deliver an estimated US$900 million in benefits to the utility's customers.
Latest
New Found Gold's Hammerdown mine enters commercial production phase
Momentum builds on the company's uplisting to the TSX last month
CATL unveils TECTRANS II truck battery with 1,000-km range
The company said commercial vehicles represent an emerging third wave of the global transition toward electric transportation
L'Oreal surpasses LVMH to become leading French stock
Its market cap is now sitting at roughly US$234 billion
American Battery Technology's massive revenue spike fails to boost shares
The firm reported a 407% jump and adjusted gross profit of US$1.7 million
BTCS expands DeFi strategy to Base as Imperium assets reach USD$36M
Imperium has expanded the amount of capital deployed through paired liquidity pools during the third quarter
Viscount identifies antimony, tellurium anomalies at Nevada project
Antimony and tellurium appear on the 2025 U.S. Critical Minerals List
Mining & Critical Minerals
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
More in Mining
Have a story we should be covering? Tips, corrections and pitches are welcome.
Contact the deskHealth & Science
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
NASDAQ: GRAL
GRAIL jumps 34% as FDA staff raise no major concerns on Galleri cancer testThe Molecular and Clinical Genetics Panel votes Wednesday on whether the multi-cancer blood test is safe, effective and worth its risks.
More in Health
Markets & Technology
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
Jinxin Technology rallies on back of AI video expansion deal
Shares had risen by 84% from last close after-hours Tuesday on Nasdaq
Energy
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
CVE: COSA
Cosa expands uranium targets with Murphy Lake North drillingCosa operates Murphy Lake North and owns a 70 per cent interest in the project.
Chile solar and wind curtailment hits record 2,680 GWh
Chile curtailed 6,084 GWh of renewable electricity during all of 2025
TSE: ISO
IsoEnergy intersects strongest radioactivity to date along Hurricane South TrendRadioactivity readings provide exploration teams with an early indication of where uranium mineralization may occur
Cannabis & Psychedelics
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
FDA psychedelics hearing draws little pushback on future therapeutic use
This meeting builds on Trump's executive order for ibogaine and other compounds in April
Psychedelic compound psilocybin shows promise for preventing chemo nerve damage
A human trial called 'NeuroGuard' is expected to commence in November
New Zealand begins prescribing MDMA for severe PTSD treatment
It is the second nation to do so after its larger neighbour Australia
Thai cannabis worker tosses tourist around for scam attempt
He tried to swindle his store out of US$875 worth of product